antibody, nucleic acid sequence, vector, pharmaceutical composition, part kit and, use of an antibody, nucleic acid sequence, vector, pharmaceutical composition or part kit
The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.